Navigation Links
Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants

in major depressive disorder: a multicenter, randomized, double-blind, placebo- controlled study (study cn138-139). Poster presentation at: annual meeting of the American Psychiatric Association, San Diego, California, Monday, May 21, 2007, 3:00 p.m. - 5:00 p.m. PST - Poster Session 3. (2) Diagnostic and Statistical Manual of Mental Disorders. Fourth ed-TR. Psychiatry Online Web site. Available at: http://www.psychiatryonline.com/content.aspx?aID=2016. Accessed April 9, 2007. (3) Kessler RC, Chiu WT, Demler OD, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62:617-627. (4) Merck Manual of Medical Information - Second Home Edition. Whitehouse Station, NJ: Merck Research Laboratories; Copyright (C) 1995-2005 Merck & Co. (5) IMS Auditrac NGPS: Abilify total monthly retail prescriptions: Data accessed 11/2006.

CONTACT: David Rosen, Bristol-Myers Squibb Company, +1-609-252-5675,Pager: +1-866-308-4484, ; or Debra Kaufmann, OtsukaAmerica Pharmaceutical, Inc., +1-240-683-3568, ;or Hideki Shirai, Otsuka Pharmaceutical Co., Ltd., +81-3-3292-0021, david.m.rosen@bms.com debra.kaufmann@otsuka.com siraih@otsuka.jp

Web site: http://www.bms.com//

Ticker Symbol: (NYSE:BMY)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents

Post Your Comments:
(Date:11/6/2009)...ll/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin ...roved reverse split of its common stock will take ...2009 on a 1-for-15 split-adjusted basis. Oxygen Bi...w symbol OXBT. The stock also will have a new CUSI...ctive. ,, "This reverse split was overwhelmingl...
(Date:11/6/2009)...PRNewswire/ -- In consultation with the U.S. Food ...lthcare, Division of McNEIL-PPC, Inc., is initiati...ct lots of TYLENOL® Arthritis Pain Caplet 100...AP. McNeil is initiating the recall after identify...with these lots that led to a small number of cons...
(Date:11/6/2009)...Therapeutics, Inc. announced today that it has fil....S. Securities and Exchange Commission (SEC) relat...s of its common stock. All shares of the common st...the Company. ,, Credit Suisse Securities (USA) ...Jaffray & Co. is acting as co-lead manager and...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 1Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 3Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 4Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 5Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 6Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 7Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 8SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 1SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 2SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 3New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 1New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 2
...ating to Company Oncology Programs to be Presented...ewswire-FirstCall/ -- Cytokinetics, Incorporated a...inical data will be,presented at the 2007 Annual M...arch (AACR) to be held from April 14- 18, 2007 in,...iple oncology,programs at Cytokinetics and will pr...
...(BUSINESS WIRE)--Apr 10, 2007 - Inotek,Pharmaceuti...n the,journal Stroke of preclinical animal data sh...) polymerase (PARP) inhibitor,has a large protecti...ollowing a stroke. PARP is a nuclear enzyme that d...n and recruitment of DNA,repair enzymes and has po...
Other Medicine Technology:Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3
(Date:11/8/2009)...HINGTON, Nov. 8 Speaker...conference following the House passage of H.R. 396...e bill passed by a vote of 220 to 215. Below are ...of my colleagues just received a call from the Pre...ulating us on a great victory for the American peo...
(Date:11/8/2009)...HINGTON, Nov. 7 Tonight...e Health Care for America Act, landmark health ref...s access to quality, affordable, stable and secure...ks down on some of the insurance industry,s worst ...ricans and cut the deficit by $104 billion over te...
(Date:11/8/2009)... New book called "Preventing ...by Dr. Roberto Giraldo shows that AIDS is a result...ariety of so-called immune system stressor agents,...al and most of all, emotional. , ...rom Nov. 6 – 8, 2009, cell biologists, physi...
(Date:11/8/2009)... 3D Global Solutions is pleased to...anaging the proposal effort for ReSound who recent...l Hearing Aid contract. The award includes not onl...ment of Defense and other federal agencies. , ... 8, 2009 -- 3D Global Solutions is pleased to anno...
(Date:11/8/2009)... Freeze-drying of biopharmaceutica...uga, Ontario facility. , ...llner, President and CEO of Therapure Biopharma In...very of a commercial scale pharmaceutical grade fr...eeze drying (lyophilization) available for contrac...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
... COLUMBUS , Ohio The chronic stress that spouses... disease patients may shorten the caregivers, live...uggests. , The research also provides concrete e...ed this month by researchers from Ohio State Unive...
...NION CITY, Calif., Sept. 18 Abaxis, Inc.,(Nasdaq:... point-of-care,blood analysis systems, announced t...present at the 2007 UBS Global Life Science Confer... presentation at, http://www.ibb.ubs.com . Click o...
... PHILADELPHIA − Human white blood cells, en..., could provide a novel therapy for patients with ...lastic leukemia (ALL), according to researchers at...s human B cells, the researchers were able to erad...
...OUNTAIN VIEW, Calif., Sept. 18 Pharsight,Corporat... of software and,strategic services for optimizing...t has filed an application to list its common stoc...r Pharsight," said Shawn,O,Connor, president, CEO,...
...assportMD Offers Safe, Secure & Free Personal Heal...t. 18 News that radio frequency,identification (R... even,cancer -- has the healthcare and personal he...nd non-invasive alternative already exists. Consum...
...onsumers Urged To Use Online Quality Information B...spital, MINNEAPOLIS, Sept. 18 The Leapfrog Group...oday released this year,s results from a,comprehen...rens, Hospitals and Clinics in Minneapolis and St....
Other Medicine News:Health News:Chronic stress can steal years from caregivers' lifetimes 2Health News:Chronic stress can steal years from caregivers' lifetimes 3Health News:Abaxis to Present at the 2007 UBS Global Life Science Conference 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 2Health News:T vs. B: Re-engineered human T cells effectively target and kill cancerous B cells 3Health News:Pharsight Files Application for Nasdaq Capital Market Listing 2Health News:Pharsight Files Application for Nasdaq Capital Market Listing 3Health News:RFID Implant Cancer Questions Concern Patients 2Health News:Four Minnesota Hospitals Rate High For Patient Safety and Quality 2
...g; and Zyplast® injectable collagen implants h...hing facial lines, wrinkles and scars and in provi...the skins natural collagen, require minimal proced...re than one million people worldwide have been tre...
Captique™ Hyaluronic Acid Dermal Filler
...ge of non-surgical facial contouring materials. Yo... results for various applications with exceptional...fers superior versatility for a wide variety of no... Long-lasting, Radiesse saves time and money for b...
HEMOCHRON Model 401 Coagulation Monitoring Instrument
Medicine Products: